Across TCGA pan-cancer cohorts, SSXP5 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated SSXP5 data layer.
The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher SSXP5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SSXP5 expression acts as an unfavorable survival marker.
PAAD, STAD, and TGCT are the cancer types where SSXP5 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.